# NIVINIHO (NCT03580408)

> Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

No report yet. It can be ordered.

- Drugs tested: nivolumab plus vinblastine; nivolumab
- Indication: elderly Hodgkin lymphoma with coexisting medical conditions

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03580408
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: The Lymphoma Academic Research Organisation
- Conditions: Hodgkin Lymphoma; Coexisting Medical Conditions
- Interventions: Nivolumab; Vinblastin
- Enrollment: 64
- Primary outcome: Complete Metabolic Response (CMR) rate (Deauville scale 1-3) at the end of treatment

## Indexed commentary on NIVINIHO so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=niviniho-nct03580408